1188 related articles for article (PubMed ID: 30232451)
21. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
22. Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.
Javidnia M; Hebron ML; Xin Y; Kinney NG; Moussa CE
J Alzheimers Dis; 2017; 60(2):461-481. PubMed ID: 28869476
[TBL] [Abstract][Full Text] [Related]
23. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
Saul A; Sprenger F; Bayer TA; Wirths O
Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
[TBL] [Abstract][Full Text] [Related]
24. Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation.
Murakami T; Paitel E; Kawarabayashi T; Ikeda M; Chishti MA; Janus C; Matsubara E; Sasaki A; Kawarai T; Phinney AL; Harigaya Y; Horne P; Egashira N; Mishima K; Hanna A; Yang J; Iwasaki K; Takahashi M; Fujiwara M; Ishiguro K; Bergeron C; Carlson GA; Abe K; Westaway D; St George-Hyslop P; Shoji M
Am J Pathol; 2006 Oct; 169(4):1365-75. PubMed ID: 17003492
[TBL] [Abstract][Full Text] [Related]
25. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.
Leroy K; Bretteville A; Schindowski K; Gilissen E; Authelet M; De Decker R; Yilmaz Z; Buée L; Brion JP
Am J Pathol; 2007 Sep; 171(3):976-92. PubMed ID: 17690183
[TBL] [Abstract][Full Text] [Related]
26. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
[TBL] [Abstract][Full Text] [Related]
27. Identification of Senescent Cells in the Bone Microenvironment.
Farr JN; Fraser DG; Wang H; Jaehn K; Ogrodnik MB; Weivoda MM; Drake MT; Tchkonia T; LeBrasseur NK; Kirkland JL; Bonewald LF; Pignolo RJ; Monroe DG; Khosla S
J Bone Miner Res; 2016 Nov; 31(11):1920-1929. PubMed ID: 27341653
[TBL] [Abstract][Full Text] [Related]
28. Cellular Senescence as the Key Intermediate in Tau-Mediated Neurodegeneration.
Mendelsohn AR; Larrick JW
Rejuvenation Res; 2018 Dec; 21(6):572-579. PubMed ID: 30489222
[TBL] [Abstract][Full Text] [Related]
29. Adenosine A
Zhao ZA; Zhao Y; Ning YL; Yang N; Peng Y; Li P; Chen XY; Liu D; Wang H; Chen X; Bai W; Chen JF; Zhou YG
Transl Psychiatry; 2017 May; 7(5):e1123. PubMed ID: 28485728
[TBL] [Abstract][Full Text] [Related]
30. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.
Chang J; Wang Y; Shao L; Laberge RM; Demaria M; Campisi J; Janakiraman K; Sharpless NE; Ding S; Feng W; Luo Y; Wang X; Aykin-Burns N; Krager K; Ponnappan U; Hauer-Jensen M; Meng A; Zhou D
Nat Med; 2016 Jan; 22(1):78-83. PubMed ID: 26657143
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
32. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.
Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H
Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748
[TBL] [Abstract][Full Text] [Related]
33. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.
Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP
J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470
[TBL] [Abstract][Full Text] [Related]
34. Astrocyte senescence and SASP in neurodegeneration: tau joins the loop.
Ungerleider K; Beck J; Lissa D; Turnquist C; Horikawa I; Harris BT; Harris CC
Cell Cycle; 2021 Apr; 20(8):752-764. PubMed ID: 33818291
[TBL] [Abstract][Full Text] [Related]
35. Effect of Nrf2 loss on senescence and cognition of tau-based P301S mice.
Riordan R; Rong W; Yu Z; Ross G; Valerio J; Dimas-Muñoz J; Heredia V; Magnusson K; Galvan V; Perez VI
Geroscience; 2023 Jun; 45(3):1451-1469. PubMed ID: 36976489
[TBL] [Abstract][Full Text] [Related]
36. Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.
Ng PY; Zhang C; Li H; Baker DJ
J Alzheimers Dis; 2024; 97(4):1751-1763. PubMed ID: 38306030
[TBL] [Abstract][Full Text] [Related]
37. Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM).
Canudas AM; Gutierrez-Cuesta J; Rodríguez MI; Acuña-Castroviejo D; Sureda FX; Camins A; Pallàs M
Mech Ageing Dev; 2005 Dec; 126(12):1300-4. PubMed ID: 16171847
[TBL] [Abstract][Full Text] [Related]
38. p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli.
Hall BM; Balan V; Gleiberman AS; Strom E; Krasnov P; Virtuoso LP; Rydkina E; Vujcic S; Balan K; Gitlin II; Leonova KI; Consiglio CR; Gollnick SO; Chernova OB; Gudkov AV
Aging (Albany NY); 2017 Aug; 9(8):1867-1884. PubMed ID: 28768895
[TBL] [Abstract][Full Text] [Related]
39. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
[TBL] [Abstract][Full Text] [Related]
40. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
